Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,320,836
-$212,837 QoQ
Shares Held
54,852
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,158
of 2,821 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hexagon Capital Partners LLC holds $11,707,728 across 11 Drug Manufacturers - General names. PFE ranks #4 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,314 | $2,092,134 | |
| 2 | MRK |
Merck & Co., Inc.
|
13,420 | $1,724,470 | |
| 3 | LLY |
ELI LILLY & Co
|
1,184 | $1,420,125 | |
| 4 | PFE |
Pfizer Inc
This page
|
54,852 | $1,320,836 | |
| 5 | JNJ |
Johnson & Johnson
|
5,167 | $1,312,262 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
18,323 | $1,055,771 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,901 | $871,872 | |
| 8 | NVS |
Novartis AG
|
3,990 | $625,312 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,320,836 | 54,852 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,533,673 | 54,618 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $1,467,581 | 58,939 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,418,675 | 55,678 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,368,251 | 56,446 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,412,198 | 55,730 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,417,312 | 53,423 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,520,333 | 52,534 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $1,416,431 | 50,623 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,097,096 | 39,535 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,185,053 | 41,162 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,262,483 | 38,061 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,381,882 | 37,674 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,422,288 | 34,860 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,542,682 | 30,107 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,462,152 | 33,413 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,174,641 | 22,404 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,069,516 | 20,659 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $1,234,853 | 20,912 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $845,361 | 19,655 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $810,142 | 20,688 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $738,476 | 20,383 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $690,334 | 18,754 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $652,929 | 17,791 | Shares | Sole | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||